1 week Ago By Defense World Staff
Corebridge Financial Inc. trimmed its holdings in shares of Inspire Medical Systems, Inc. (NYSE:INSP – Free Report) by 8.
0% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 1,596 shares of the company’s stock after selling 138 shares during the quarter. Corebridge Financial Inc.
’s holdings in Inspire Medical Systems were worth $296,000 at the end of the most recent quarter. Several other institutional investors also recently bought and sold shares of INSP. First Horizon Advisors Inc.
increased its holdings in shares of Inspire Medical Systems by 885.7% during the 4th quarter. First Horizon Advisors Inc.
now owns 138 shares of the company’s stock valued at $26,000 after acquiring an additional 124 shares during the last quarter. Harbour Investments Inc. boosted its position in Inspire Medical Systems by 101.
0% during the fourth quarter. Harbour Investments Inc. now owns 197 shares of the company’s stock worth $37,000 after purchasing an additional 99 shares during the period.
AlphaQuest LLC grew its holdings in Inspire Medical Systems by 7,275.0% during the fourth quarter. AlphaQuest LLC now owns 295 shares of the company’s stock valued at $55,000 after purchasing an additional 291 shares during the last quarter.
Smartleaf Asset Management LLC raised its position in shares of Inspire Medical Systems by 178.9% in the fourth quarter. Smartleaf Asset Management LLC now owns 357 shares of the company’s stock valued at $66,000 after purchasing an additional 229 shares during the period.
Finally, Nisa Investment Advisors LLC lifted its stake in shares of Inspire Medical Systems by 37.3% in the fourth quarter. Nisa Investment Advisors LLC now owns 368 shares of the company’s stock worth $68,000 after buying an additional 100 shares during the last quarter.
94.91% of the stock is currently owned by institutional investors. Inspire Medical Systems Price PerformanceINSP opened at $144.
49 on Friday. Inspire Medical Systems, Inc. has a fifty-two week low of $123.
00 and a fifty-two week high of $257.40. The company has a market capitalization of $4.
30 billion, a P/E ratio of 83.52, a P/E/G ratio of 2.86 and a beta of 1.
39. The firm’s fifty day moving average price is $170.67 and its two-hundred day moving average price is $185.
70. Inspire Medical Systems (NYSE:INSP – Get Free Report) last posted its earnings results on Monday, February 10th. The company reported $1.
15 earnings per share for the quarter, beating analysts’ consensus estimates of $0.74 by $0.41.
Inspire Medical Systems had a net margin of 6.67% and a return on equity of 8.19%.
On average, equities research analysts expect that Inspire Medical Systems, Inc. will post 2.16 EPS for the current fiscal year.
Insider Transactions at Inspire Medical SystemsIn related news, CTO John Rondoni sold 583 shares of the stock in a transaction dated Tuesday, February 11th. The shares were sold at an average price of $170.49, for a total transaction of $99,395.
67. Following the completion of the sale, the chief technology officer now owns 10,424 shares in the company, valued at $1,777,187.76.
This trade represents a 5.30 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website.
Also, insider Randy Ban sold 25,584 shares of the business’s stock in a transaction dated Thursday, February 13th. The shares were sold at an average price of $183.50, for a total transaction of $4,694,664.
00. Following the completion of the transaction, the insider now owns 7,259 shares in the company, valued at approximately $1,332,026.50.
This trade represents a 77.90 % decrease in their ownership of the stock. The disclosure for this sale can be found here.
2.30% of the stock is currently owned by insiders. Analyst Ratings ChangesA number of research analysts recently issued reports on the stock.
Truist Financial lowered their target price on shares of Inspire Medical Systems from $250.00 to $235.00 and set a “buy” rating on the stock in a research note on Tuesday, February 11th.
Wells Fargo & Company cut their price objective on Inspire Medical Systems from $198.00 to $195.00 and set an “equal weight” rating for the company in a research report on Tuesday, February 11th.
Robert W. Baird lowered their target price on Inspire Medical Systems from $252.00 to $248.
00 and set an “outperform” rating on the stock in a report on Tuesday, February 11th. Stifel Nicolaus cut their price target on Inspire Medical Systems from $200.00 to $190.
00 and set a “hold” rating for the company in a report on Tuesday, January 21st. Finally, Morgan Stanley reduced their price objective on Inspire Medical Systems from $230.00 to $220.
00 and set an “overweight” rating for the company in a research report on Tuesday, February 11th. Three investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. Based on data from MarketBeat.
com, the company has a consensus rating of “Moderate Buy” and an average price target of $226.70.View Our Latest Stock Report on Inspire Medical SystemsInspire Medical Systems Profile (Free Report)Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally.
The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.Recommended StoriesFive stocks we like better than Inspire Medical Systems3 Fintech Stocks With Good 2021 ProspectsJoby Aviation: Operational Momentum vs. Market SentimentThe Top 3 Healthcare Dividend Stocks to Buy and HoldBroadcom’s Big Outperformance Shows Strength Amid Tariff DeclineNatural Gas Prices Continue To Rally, These Stocks Should BenefitCarvana: Can Turnaround Strength Outdrive Market Headwinds?Want to see what other hedge funds are holding INSP? Visit HoldingsChannel.
com to get the latest 13F filings and insider trades for Inspire Medical Systems, Inc. (NYSE:INSP – Free Report)..
